Korean J Pathol.
2000 May;34(5):341-348.
Expression of p27Kip1 Protein in Carcinoma of the Urinary Bladder
- Affiliations
-
- 1Department of Pathology and Medical Institute, Dongguk University College of Medicine, Kyungju 780-714, Korea.
Abstract
-
The cyclin-dependent kinase (cdk) inhibitor p27Kip1 gene is a powerful molecular
determinant of cell cycle progression. Loss of expression of p27Kip1 has recently been shown to be
predictive of disease progression in several human malignancies. The prognostic value and
expression of p27Kip1 have been incompletely studied in bladder cancer. In this study, we
investigated the relationship between p27Kip1 protein expression and clinicopathologic parameters in
50 cases of carcinoma of the urinary bladder by conducting immunohistochemical analysis and
DNA flow-cytometry. Malignant bladder tissue demonstrated a heterogeneous pattern of p27Kip1
immunoreactivity. In addition, there was progressive loss of expression with increasing tumor
grade. The expression of p27Kip1 protein was unrelated to stage, DNA ploidy and S phase fraction
(SPF). SPF was unrelated with tumor grade and DNA ploidy. The results indicate that p27Kip1 is
frequently expressed in well differentiated transitional cell carcinomas of the urinary bladder but
less often expressed in muscle-invasive transitional cell carcinomas. The expression of p27Kip1 and
its prevalence in low-grade tumors may reflect growth regulatory influences and potential
inhibiting action in tumor progression and novel predictive markers of the biological potential of
bladder tumors.